About this trial
The Optic Nerve Sheath Diameter (ONSD), measured non-invasively by bedside ultrasound, is a well-established surrogate for intracranial pressure (ICP), as the optic nerve sheath is continuous with the intracranial dura mater and its subarachnoid space is filled with cerebrospinal fluid (CSF). While ONSD is typically used to detect elevated ICP (with a cut-off often \> 5.0-5.7 mm for ICP \> 20 mmHg), studies investigating PDPH have paradoxically shown a reduction in ONSD post-spinal anesthesia, correlating with the state of intracranial hypotension.
Previous research has demonstrated that a lower ONSD or a significant decrease in ONSD values 24 hours post-puncture is associated with PDPH development. A study determined that an ONSD at 24 hours of less than 0.40 cm was the best predictor for PDPH. Our study aims to specifically investigate the utility of the immediate change in ONSD to offer a bedside, real-time assessment of risk.
Eligibility criteria
Qualifiers
Adult female patients, aged 18-45 years
ASA(American Society of Anesthesiologists) physical status II or III
Scheduled for elective cesarean section
Undergoing surgery under standardized spinal anesthesia
Disqualifiers
Pre-existing headache disorders (e.g., migraine, chronic tension-type headache)
Known ophthalmic conditions (e.g., optic neuropathy, glaucoma)
Inability to cooperate with ONSD(Optic Nerve Sheath Diameter) ultrasound measurements or follow-up
Allergy to local anesthetics
Trial design
Treatments tested in this trial
- Study Cohort (Single Cohort)
Treatment groups
Sponsors and collaborators
Al-Azhar University
Lead sponsor
Benha University
Collaborator